IMPACT OF A COMMUNITY PHARMACY-BASED INFORMATION PROGRAM ON TYPE 2 DIABETIC PATIENTS’ ADHERENCE TO THEIR ORAL TREATMENT- IPHODIA, A CLUSTER RANDOMIZED STUDY VS USUAL PRACTICE
Author(s)
Michiels Y1, Bugnon O2, Chicoye A3, Verges B4, Moisan C5, Mechin H6, Allaert F7
1Community Pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne,, Lausanne, Switzerland, 2School of pharmaceutical sciences, University of Geneva, Lausanne, Switzerland, 3Institute of Health Economics and Management ESSEC, Cergy-Pontoise, France, 4CHU Dijon, Dijon, France, 5MSD, Courbevoie, France, 6Observia, Paris, France, 7Medical evaluation Chair ESC Dijon, Dijon, France
Conference/Value in Health Info
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PDB61
Topic
Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance
Disease
Diabetes/Endocrine/Metabolic Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now